vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Tectonic Financial, Inc. (TECTP). Click either name above to swap in a different company.
Tectonic Financial, Inc. is the larger business by last-quarter revenue ($23.0M vs $13.8M, roughly 1.7× Gossamer Bio, Inc.). Tectonic Financial, Inc. runs the higher net margin — 23.8% vs -342.3%, a 366.2% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 17.9%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Tectonic Financial, Inc.TECTPEarnings & Financial Report
Tectonic Financial, Inc. is a US-based diversified financial services provider. It offers core services including wealth management, investment banking, capital markets advisory, and tailored financial solutions. Its key client segments cover high-net-worth individuals, institutional investors, and small to mid-sized enterprises across North America.
GOSS vs TECTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $23.0M |
| Net Profit | $-47.2M | $5.5M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 30.6% |
| Net Margin | -342.3% | 23.8% |
| Revenue YoY | 47.1% | 17.9% |
| Net Profit YoY | -43.0% | 15.9% |
| EPS (diluted) | $-0.21 | $0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | $23.0M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | — | $21.8M | ||
| Q4 24 | — | $21.4M | ||
| Q3 24 | — | $19.5M | ||
| Q2 24 | $95.8M | $18.6M | ||
| Q1 24 | $0 | $17.6M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | $5.5M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | $49.2M | $3.1M | ||
| Q1 24 | $-41.9M | $3.1M |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | 30.6% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | 26.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 29.1% | ||
| Q2 24 | 54.3% | 21.5% | ||
| Q1 24 | — | 22.2% |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | 23.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 20.4% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 24.2% | ||
| Q2 24 | 51.4% | 16.9% | ||
| Q1 24 | — | 17.4% |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | $0.73 | ||
| Q2 25 | — | $0.55 | ||
| Q1 25 | — | $0.57 | ||
| Q4 24 | — | $0.35 | ||
| Q3 24 | — | $0.58 | ||
| Q2 24 | $0.22 | $0.38 | ||
| Q1 24 | $-0.19 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $119.2M |
| Total Assets | $172.2M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $354.5M | — | ||
| Q1 24 | $244.4M | — |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | $119.2M | ||
| Q2 25 | — | $114.6M | ||
| Q1 25 | — | $111.3M | ||
| Q4 24 | — | $113.4M | ||
| Q3 24 | — | $112.8M | ||
| Q2 24 | $81.5M | $110.4M | ||
| Q1 24 | $26.7M | $108.5M |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | $1.1B | ||
| Q2 25 | — | $997.0M | ||
| Q1 25 | — | $910.5M | ||
| Q4 24 | — | $863.4M | ||
| Q3 24 | — | $847.5M | ||
| Q2 24 | $373.4M | $777.1M | ||
| Q1 24 | $259.4M | $777.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-17.3M |
| Free Cash FlowOCF − Capex | — | $-17.3M |
| FCF MarginFCF / Revenue | — | -74.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -3.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | $-17.3M | ||
| Q2 25 | — | $-32.5M | ||
| Q1 25 | — | $-35.6M | ||
| Q4 24 | — | $-86.6M | ||
| Q3 24 | — | $-22.5M | ||
| Q2 24 | $116.3M | $-30.7M | ||
| Q1 24 | $-52.3M | $-3.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-17.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-35.6M | ||
| Q4 24 | — | $-86.8M | ||
| Q3 24 | — | $-22.5M | ||
| Q2 24 | — | $-30.7M | ||
| Q1 24 | — | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -74.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -163.2% | ||
| Q4 24 | — | -406.5% | ||
| Q3 24 | — | -115.0% | ||
| Q2 24 | — | -165.5% | ||
| Q1 24 | — | -18.8% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -3.14× | ||
| Q2 25 | — | -7.61× | ||
| Q1 25 | — | -8.00× | ||
| Q4 24 | — | -28.99× | ||
| Q3 24 | — | -4.74× | ||
| Q2 24 | 2.36× | -9.76× | ||
| Q1 24 | — | -1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
